New stent graft aims to restore blood flow in legs without major surgery

NCT ID NCT04130737

Completed Disease control Sponsor: Endologix Source: ClinicalTrials.gov ↗

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This trial evaluates a device called the TORUS Stent Graft, a mesh tube placed inside the leg artery to keep it open in people with peripheral artery disease (PAD). The study includes about 188 adults with blockages in the thigh or behind-the-knee arteries. The goal is to see if the stent graft safely improves blood flow and reduces the need for further procedures or amputation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: TORUS Stent Graft System
What this could lead to: If successful, this device could offer a less invasive way to reopen blocked leg arteries, potentially reducing the need for repeat procedures or major surgery.
What could go wrong: This is a device study with risks including bleeding, infection, or the stent graft failing to stay open. Long-term benefits are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERIPHERAL ARTERIAL DISEASE

Contacts and locations

Show contact details

Locations

AMITA Health

Elk Grove, Illinois, 60007, United States
Arkansas Heart

Little Rock, Arkansas, 72211, United States
Bay Area Vein & Vascular Institute

Burlingame, California, 94010, United States
Bellin Hospital

Green Bay, Wisconsin, 54301, United States
Coastal Vascular & Interventional

Pensacola, Florida, 32504, United States
Columbia University Medical Center

New York, New York, 10032, United States
Eastlake Cardiovascular

Roseville, Michigan, 48066, United States
First Coast Cardiovascular Institute

Jacksonville, Florida, 32256, United States
Florida Cardiology

Winter Park, Florida, 32792, United States
McLaren Bay Region

Bay City, Michigan, 48708, United States
MedStar Health Research Insitute

Hyattsville, Maryland, 20782, United States
Michigan Vascular Center

Flint, Michigan, 48507, United States
NC Heart & Vascular Research

Raleigh, North Carolina, 27607, United States
Naadi

Oklahoma City, Oklahoma, 73116, United States
North Central Heart

Sioux Falls, South Dakota, 57108, United States
North Dallas Research Associates

McKinney, Texas, 75069, United States
Northern Mississippi Medical Center

Tupelo, Mississippi, 38801, United States
Novant Health

Charlotte, North Carolina, 28204, United States
Palm Vascular Centers

Miami Beach, Florida, 33140, United States
Phoenix Cardiovascular Research Group

Phoenix, Arizona, 85018, United States
Prisma Health

Greenville, South Carolina, 29615, United States
Rocky Mountain Regional VAMC

Aurora, Colorado, 80045, United States
Sentara Vascular Specialists

Norfolk, Virginia, 23507, United States
Southwest CVA

Mesa, Arizona, 85206, United States
Stern Cardiovascular Foundation

Germantown, Tennessee, 38138, United States
Texas Tech

Lubbock, Texas, 79430, United States
The Lindner Center for Research & Education

Cincinnati, Ohio, 45219, United States
The Miriam Hospital

Providence, Rhode Island, 02906, United States
The Vascular Experts

Darien, Connecticut, 06820, United States
UCSF

San Francisco, California, 94143, United States
Vascular Heart & Lung Associates

Mesa, Arizona, 85206, United States
Yuma Cardiology Associates

Yuma, Arizona, 85349, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.